Search

Your search keyword '"Biagini E."' showing total 610 results

Search Constraints

Start Over You searched for: Author "Biagini E." Remove constraint Author: "Biagini E."
610 results on '"Biagini E."'

Search Results

1. X-linked Emery-Dreifuss muscular dystrophy is associated with a high risk of malignant ventricular arrhythmia

2. Electrocardiographic evolution in Anderson-Fabry disease: a valuable tool to detect progressive cardiac involvement

3. The potential role of the aortic valve calcium score by computed tomography scan in the diagnosis of concomitant cardiac amyloidosis in patients with severe aortic stenosis

5. Characterization and natural history of phenotypes in hereditary transthyretin amyloidosis

6. Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up

7. Acute changes of right ventricular longitudinal strain after transcatheter edge-to-edge repair in patients with functional mitral regurgitation

8. Arrhythmic risk stratification in patients with left ventricular ring-like scar

9. Myocardial inflammation in Fabry disease: correlations between myocardial histology, T2 mapping, and troponin

10. Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study

11. From the phenotype to precision medicine: An update on the cardiomyopathies diagnostic workflow

12. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study

13. Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis]

14. Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation

15. Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking

16. Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study

18. Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis]

19. Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey

20. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

21. Risk stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: the impact of genotype on the 2019 ARVC risk calculator

22. ECG as a storytelling of cardiac involvement evolution in Anderson Fabry disease

23. Prognostic implications of biventricular uptake of bone tracers at planar scintigraphy in transthyretin cardiac amyloidosis

24. Electrocardiographic evolution in Anderson-Fabry disease patients on and off specific therapy: a potential marker to study the therapeutic cardiac goal

25. Diagnostic pathways leading to arrhythmogenic left ventricular cardiomyopathy in a single center cohort

26. Electrocardiographic findings in Anderson-Fabry patients on disease specific therapy: can treatment prevent ECG changes?

27. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

28. Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey

29. C64 UNMASKING THE PREVALENCE OF AMYLOID CARDIOMYOPATHY IN THE REAL WORLD: RESULTS FROM PHASE 2 OF AC–TIVE STUDY, AN ITALIAN NATIONWIDE SURVEY

30. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.

31. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.

32. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study

33. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry

34. Different aortic valve calcium scores by computed tomography scan in patients with severe aortic stenosis and concomitant cardiac amyloidosis

35. Analysis of characteristics and prognostic impact of phenotypes in hereditary ATTR

39. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity

40. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy

43. Mortality among Referral Patients with Hypertrophic Cardiomyopathy vs the General European Population

44. Prospective follow-up in various subtypes of cardiomyopathies: Insights from the EORP Cardiomyopathy Registry of the ESC

45. Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation

47. Cardiac tissue characterization with t1 and t2 mapping in anderson fabry patients: new pathophysiological concepts and early cardiac involvement

48. Electrocardiographic differences between Anderson-Fabry and sarcomeric hypertrophic cardiomyopathy and correlation with cardiac magnetic resonance

50. P663 Is echocardiogram alone sufficient for cardiac masses characterization?

Catalog

Books, media, physical & digital resources